Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation-Reference-Cited by-同舟云学术

Cutaneous delivery of [1-(4-chloro-3-nitrobenzenesulfonyl)-1H-indol-3-yl]-methanol, an indole-3-carbinol derivative, mitigates psoriasiform lesion by blocking MAPK/NF-κB/AP-1 activation

Published:2019-11 Issue: Volume:119 Page:109398
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Weng Jing-Ru,Huang Tse-Hung,Lin Zih-Chan,Alalaiwe Ahmed,Fang Jia-You

Funder

Ministry of Science and Technology of Taiwan

Chang Gung Memorial Hospital

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference47 articles.

1. Psoriasis prevalence among the 2009 AAD national melanoma/skin cancer screening program participants;Lima;J. Eur. Acad. Dermatol. Venereol.,2013

2. Psoriasis-associated cutaneous pain: etiology, assessment, impact, and management;Pithadia;J. Dermatol. Treat.,2018

3. Psoriasis: from pathogenesis to targeted therapies;Conrad;Clin. Rev. Allergy Immunol.,2018

4. The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis;Albanesi;Front. Immunol.,2018

5. Psoriasis;Boehncke;Lancet,2015

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical techniques for drug discovery in psoriasis;International Immunopharmacology;2024-08

2. An alkaloid-rich phytopharmaceutical prepared from Qing Dai against IL-17A-induced psoriasis;Journal of Ethnopharmacology;2024-01

3. Natural alternatives targeting psoriasis pathology and key signaling pathways: a focus on phytochemicals;Phytochemistry Reviews;2023-07-18

4. The elucidation of structure–activity and structure-permeation relationships for the cutaneous delivery of phytosterols to attenuate psoriasiform inflammation;International Immunopharmacology;2023-06

5. Targeting Nrf2 with 3 H-1,2-dithiole-3-thione to moderate OXPHOS-driven oxidative stress attenuates IL-17A-induced psoriasis;Biomedicine & Pharmacotherapy;2023-03